AWM
VRTX icon

Atticus Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Atticus Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-143
Closed -$63.7K – 634
2025
Q2 		$63.7K Buy
143
+3
+2% +$1.38K 0.02% 290
2025
Q1 		$67.9K Hold
140
– – 0.02% 200
2024
Q4 		$56.4K Buy
140
+125
+833% +$57.9K 0.02% 234
2024
Q3 		$6.98K Sell
15
-4
-21% -$1.92K ﹤0.01% 414
2024
Q2 		$8.91K Hold
19
– – ﹤0.01% 395
2024
Q1 		$7.94K Hold
19
– – ﹤0.01% 420
2023
Q4 		$7.73K Hold
19
– – ﹤0.01% 425
2023
Q3 		$6.61K Hold
19
– – ﹤0.01% 440
2023
Q2 		$6.69K Hold
19
– – ﹤0.01% 427
2023
Q1 		$5.99K Buy
19
+15
+375% +$4.5K ﹤0.01% 424
2022
Q4 		$1.16K Sell
4
-20
-83% -$6.09K ﹤0.01% 484
2022
Q3 		$7K Hold
24
– – ﹤0.01% 409
2022
Q2 		$7K Buy
24
+7
+41% +$1.87K ﹤0.01% 440
2022
Q1 		$4K Buy
+17
New +$4.04K ﹤0.01% 484
2021
Q3 		– Sell
-347
Closed -$70K – 458
2021
Q2 		$70K Sell
347
-1,380
-80% -$289K 0.03% 199
2021
Q1 		$371K Buy
1,727
+897
+108% +$197K 0.18% 76
2020
Q4 		$196K Buy
830
+415
+100% +$95.2K 0.1% 98
2020
Q3 		$113K Buy
415
+410
+8,200% +$113K 0.07% 128
2020
Q2 		$1K Hold
5
– – ﹤0.01% 291
2020
Q1 		$1K Hold
5
– – ﹤0.01% 296
2019
Q4 		$1K Buy
+5
New +$1.01K ﹤0.01% 370

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Atticus Wealth Management's VRTX Position: Q3 2025 in Review

Atticus Wealth Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 143 shares — an estimated $63.7K sold.

Atticus Wealth Management first reported a position in VRTX in Q4 2019 and held it in 21 quarters. The position peaked at $371K in Q1 2021. 1,521 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Atticus Wealth Management reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 143 Vertex Pharmaceuticals shares in Q3 2025, an estimated $63.7K.
  • Atticus Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2019 and held it in 21 quarters.
  • Atticus Wealth Management's Vertex Pharmaceuticals position peaked at $371K in Q1 2021.
  • 1,521 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.